NNNN earnings date and last-quarter result: P/E 48.86. Updated 2026-07-23.
Anbio Biotechnology (NNNN) Research Hub
Anbio Biotechnology (NNNN) trades on NASDAQ, DE in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-10-26, shares last closed at 3.7 USD (-2.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 48.86, market cap 0.41B. This hub links to the full technical, earnings and options research available for NNNN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, DE |
| Last close | 3.7 USD (-2.89%) |
| 52-week range | 3.09 USD – 17.55 USD |
| Trend regime | Range |
| 14-day RSI | 27.6 (Oversold) |
| Trailing P/E | 48.86 |
| Market cap | 0.41B |
| Dividend yield | 0.00% |
Available research for NNNN
Covered Call on NNNN: how it works, illustrative setup around the real 3.7 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NNNN: how it works, illustrative setup around the real 3.7 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NNNN: how it works, illustrative setup around the real 3.7 USD price, max profit/loss, breakeven and when to use it. Educational.
NNNN technical analysis: range, last 3.7 USD, RSI 27.6, 52w range 3.09 USD–17.55 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NNNN in?
Anbio Biotechnology (NNNN) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, DE.
Is NNNN in an uptrend or downtrend?
As of 2026-10-26, NNNN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NNNN's trailing P/E ratio?
NNNN's trailing P/E is 48.86, with a market cap of 0.41B. See the earnings research page for full valuation detail.